What is the purpose and procedure of a Hida (Hepatobiliary Iminodiacetic Acid) scan in diagnosing gallbladder disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HIDA Scan in Diagnosing Gallbladder Disease

Purpose and Clinical Role

HIDA scan (hepatobiliary iminodiacetic acid scan) is a nuclear medicine imaging test that uses a radiotracer extracted by hepatocytes and excreted through the biliary system to diagnose cystic duct obstruction in acute cholecystitis, with the highest sensitivity (84.2-89.3%) and specificity among imaging modalities for this indication. 1

The primary diagnostic purpose is detecting cystic duct obstruction—when the gallbladder fails to visualize on HIDA scan, this indicates obstruction and confirms acute cholecystitis. 2, 3

When to Order a HIDA Scan

Diagnostic Algorithm for Acute Cholecystitis

Start with ultrasound as first-line imaging for suspected acute cholecystitis (sensitivity 73%, specificity 83%). 1, 4

If ultrasound is equivocal or non-diagnostic and clinical suspicion persists:

  • Proceed to CT scan as the next step in non-pregnant adults 1
  • If both ultrasound AND CT remain equivocal/non-diagnostic, then obtain HIDA scan or MRI/MRCP 1

This stepwise approach is critical—HIDA scan is reserved for cases where initial imaging is inconclusive, not as a first-line test. 1, 4

Comparative Diagnostic Performance

HIDA scan demonstrates superior sensitivity compared to other modalities:

  • HIDA sensitivity: 84.2-89.3% 1
  • Ultrasound sensitivity: 67.3-73% 1, 4
  • CT sensitivity: 59.8% 1

The specificity ranges from 66.8-83% depending on the study. 1

Procedure and Technical Aspects

Patient Preparation Requirements

Patients must fast for 4-6 hours (optimally overnight) before the scan to ensure the gallbladder is adequately filled with bile. 4

Critical medication restrictions:

  • Withhold anticholinergic drugs for at least 48 hours before scanning, as they impair gallbladder contraction and cause false-positive results 4
  • Withhold opiates for at least 48 hours 4
  • Avoid nifedipine, indomethacin, octreotide, theophylline, benzodiazepines, and progesterone within 24 hours 4
  • Avoid nicotine and alcohol 4

How the Scan Works

The radiotracer (99mTc-HIDA) is administered intravenously and follows the same pathway as bilirubin:

  • Hepatocytes extract the tracer from blood 2, 5
  • The tracer is excreted into the biliary system 2, 5
  • Normal gallbladders visualize within 30-60 minutes 3, 5
  • Non-visualization of the gallbladder indicates cystic duct obstruction and acute cholecystitis 2, 3

CCK-Augmented HIDA Scan (Different Indication)

When CCK is Added

CCK-augmented HIDA scanning measures gallbladder ejection fraction (GBEF) and is indicated for functional gallbladder disorder (biliary dyskinesia) and chronic acalculous cholecystitis—NOT for acute calculous cholecystitis. 4

The standardized protocol uses 0.02 μg/kg sincalide infused over 60 minutes, with normal GBEF defined as ≥38%. 4, 6

Important Caveat About CCK-HIDA

CCK-augmented HIDA is NOT indicated for acute calculous cholecystitis where cystic duct obstruction is already present. 4 The controversy exists because studies show symptom resolution after cholecystectomy occurs in 66-77% of patients regardless of HIDA results when typical biliary symptoms are present. 7

For patients with atypical symptoms, a positive CCK-HIDA (low GBEF <38%) does predict better symptom improvement (64% vs 43%, p=0.013). 7

Clinical Limitations and Pitfalls

Resource Constraints

HIDA scan utilization in clinical practice is limited due to required resources, time, and availability—this is why it's positioned as third-line imaging after ultrasound and CT. 1

Diagnostic Limitations

HIDA scan has qualified value when bilirubin exceeds 5 mg/dL because hepatocyte uptake and biliary excretion are impaired in severe hyperbilirubinemia. 5

HIDA cannot visualize the gallbladder in 42% of patients with hepatocellular disease due to poor uptake or secretion of the tracer. 3

Common Pitfall to Avoid

Do not use rapid CCK infusion (<30 minutes), as this causes non-specific abdominal symptoms that confound interpretation. 6 Always use the standardized 60-minute infusion protocol for reliable results.

Other Diagnostic Applications

Beyond acute cholecystitis, HIDA scan can diagnose:

  • High-grade biliary obstruction (shows persistent hepatogram without biliary clearance) 2
  • Biliary leakage post-cholecystectomy or liver transplantation 2
  • Partial biliary obstruction from stones or strictures 2

Pregnancy Considerations

In pregnant patients with suspected acute cholecystitis, ultrasound or MRI can be considered as initial imaging to avoid radiation exposure—the guidelines cannot recommend one over the other. 1 HIDA scan involves radiation and is generally avoided in pregnancy unless absolutely necessary.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nuclear medicine hepatobiliary imaging.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2010

Research

HIDA scanning in gall-bladder disease.

The British journal of radiology, 1980

Guideline

Diagnostic Approach for Gallstone Cholecystitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gallbladder Ejection Fraction Measurement and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.